Tomocube, Inc. (KOSDAQ:475960)

South Korea flag South Korea · Delayed Price · Currency is KRW
51,500
+1,500 (3.00%)
At close: Apr 10, 2026
Market Cap689.24B +236.3%
Revenue (ttm)11.31B +90.4%
Net Income-4.81B
EPS-365.00
Shares Out13.38M
PE Ration/a
Forward PE190.04
Dividendn/a
Ex-Dividend Daten/a
Volume43,045
Average Volume102,497
Open51,100
Previous Close50,000
Day's Range49,800 - 51,900
52-Week Range13,490 - 67,800
Betan/a
RSI44.95
Earnings DateApr 3, 2026

About Tomocube

Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to accommodate both adherent and suspension cells; TomoChamber, a stage-top incubator designed for long-term live cell imaging; TomoPlate, an active vibrat... [Read more]

Industry Laboratory Apparatus and Furniture
Founded 2015
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 475960
Full Company Profile

Financial Performance

In 2025, Tomocube's revenue was 11.31 billion, an increase of 90.39% compared to the previous year's 5.94 billion. Losses were -4.81 billion, -42.06% less than in 2024.

Financial Statements